Continuation Study for Latozinemab

Clinical trial NCT06111014 · TERMINATED

Trial details

NCT number: NCT06111014
Sponsor: Alector Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Neurodegenerative Diseases

Start date: 2023-12-08
Primary completion: 2025-09-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.